{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T10:41:23Z","timestamp":1773657683127,"version":"3.50.1"},"reference-count":32,"publisher":"American Society of Hematology","issue":"4","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2003,2,15]]},"abstract":"<jats:p>We established the molecular basis for pyruvate kinase (PK) deficiency in a white male patient with severe nonspherocytic hemolytic anemia. The paternal allele exhibited the commonPKLR cDNA sequence (c.) 1529G&gt;A mutation, known to be associated with PK deficiency. On the maternal allele, 3 in cis mutations were identified in the erythroid-specific promoter region of the gene: one deletion of thymine \u2212248 and 2 single nucleotide substitutions, nucleotide (nt) \u2212324T&gt;A and nt \u221283G&gt;C. Analysis of the patient's RNA demonstrated the presence of only the 1529A allele, indicating severely reduced transcription from the allele linked to the mutated promoter region. Transfection of promoter constructs into erythroleukemic K562 cells showed that the most upstream \u2212324T&gt;A and \u2212248delT mutations were nonfunctional polymorphisms. In contrast, the \u221283G&gt;C mutation strongly reduced promoter activity. Site-directed mutagenesis of the promoter region revealed the presence of a putative regulatory element (PKR-RE1) whose core binding motif, CTCTG, is located between nt \u221287 and nt \u221283. Electrophoretic mobility shift assay using K562 nuclear extracts indicated binding of an as-yet-unidentified trans-acting factor. This novel element mediates the effects of factors necessary for regulation of pyruvate kinase gene expression during red cell differentiation and maturation.<\/jats:p>","DOI":"10.1182\/blood-2002-07-2321","type":"journal-article","created":{"date-parts":[[2003,1,30]],"date-time":"2003-01-30T21:36:12Z","timestamp":1043962572000},"page":"1596-1602","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":44,"title":["Disruption of a novel regulatory element in the erythroid-specific promoter of the human PKLR gene causes severe pyruvate kinase deficiency"],"prefix":"10.1182","volume":"101","author":[{"given":"Richard","family":"van Wijk","sequence":"first","affiliation":[{"name":"From the Department of Clinical Chemistry and the Department of Hematology, University Medical Center Utrecht, The Netherlands; the EMBL Mouse Biology Programme, Monterotondo-Scalo (RM), Italy; the Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA; and the Department of Clinical Biochemistry, Rigshospitalet, Copenhagen, Denmark."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wouter W.","family":"van Solinge","sequence":"additional","affiliation":[{"name":"From the Department of Clinical Chemistry and the Department of Hematology, University Medical Center Utrecht, The Netherlands; the EMBL Mouse Biology Programme, Monterotondo-Scalo (RM), Italy; the Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA; and the Department of Clinical Biochemistry, Rigshospitalet, Copenhagen, Denmark."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claus","family":"Nerlov","sequence":"additional","affiliation":[{"name":"From the Department of Clinical Chemistry and the Department of Hematology, University Medical Center Utrecht, The Netherlands; the EMBL Mouse Biology Programme, Monterotondo-Scalo (RM), Italy; the Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA; and the Department of Clinical Biochemistry, Rigshospitalet, Copenhagen, Denmark."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernest","family":"Beutler","sequence":"additional","affiliation":[{"name":"From the Department of Clinical Chemistry and the Department of Hematology, University Medical Center Utrecht, The Netherlands; the EMBL Mouse Biology Programme, Monterotondo-Scalo (RM), Italy; the Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA; and the Department of Clinical Biochemistry, Rigshospitalet, Copenhagen, Denmark."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terri","family":"Gelbart","sequence":"additional","affiliation":[{"name":"From the Department of Clinical Chemistry and the Department of Hematology, University Medical Center Utrecht, The Netherlands; the EMBL Mouse Biology Programme, Monterotondo-Scalo (RM), Italy; the Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA; and the Department of Clinical Biochemistry, Rigshospitalet, Copenhagen, Denmark."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gert","family":"Rijksen","sequence":"additional","affiliation":[{"name":"From the Department of Clinical Chemistry and the Department of Hematology, University Medical Center Utrecht, The Netherlands; the EMBL Mouse Biology Programme, Monterotondo-Scalo (RM), Italy; the Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA; and the Department of Clinical Biochemistry, Rigshospitalet, Copenhagen, Denmark."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Finn C.","family":"Nielsen","sequence":"additional","affiliation":[{"name":"From the Department of Clinical Chemistry and the Department of Hematology, University Medical Center Utrecht, The Netherlands; the EMBL Mouse Biology Programme, Monterotondo-Scalo (RM), Italy; the Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA; and the Department of Clinical Biochemistry, Rigshospitalet, Copenhagen, Denmark."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"key":"2019111822183763800_B1","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1053\/beha.1999.0057","article-title":"Red cell pyruvate kinase deficiency: from genetics to clinical manifestations.","volume":"13","author":"Zanella","year":"2000","journal-title":"Baillieres Best Pract Res Clin Haematol."},{"key":"2019111822183763800_B2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1006\/bcmd.2000.0276","article-title":"Hematologically important mutations: red cell pyruvate kinase (third update).","volume":"26","author":"Bianchi","year":"2000","journal-title":"Blood Cells Mol Dis."},{"key":"2019111822183763800_B3","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1159\/000132530","article-title":"The human liver-type pyruvate kinase (PKL) gene is on chromosome 1 at band q21.","volume":"47","author":"Satoh","year":"1988","journal-title":"Cytogenet Cell Genet."},{"key":"2019111822183763800_B4","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1073\/pnas.85.6.1792","article-title":"Human liver type pyruvate kinase: complete amino acid sequence and the expression in mammalian cells.","volume":"85","author":"Tani","year":"1988","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2019111822183763800_B5","doi-asserted-by":"crossref","first-page":"8218","DOI":"10.1073\/pnas.88.18.8218","article-title":"cDNA cloning of human R-type pyruvate kinase and identification of a single amino acid substitution (Thr384\u2192Met) affecting enzymatic stability in a pyruvate kinase variant (PK Tokyo) associated with hereditary hemolytic anemia.","volume":"88","author":"Kanno","year":"1991","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2019111822183763800_B6","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3109\/10425179709020884","article-title":"Complete genomic sequence of the human PK-L\/R-gene includes four intragenic polymorphisms defining different haplotype backgrounds of normal and mutant PK-genes.","volume":"8","author":"Lenzner","year":"1997","journal-title":"DNA Seq."},{"key":"2019111822183763800_B7","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/292070a0","article-title":"One gene, but two messenger RNAs encode liver L and red cell L' pyruvate kinase subunits.","volume":"292","author":"Marie","year":"1981","journal-title":"Nature."},{"key":"2019111822183763800_B8","doi-asserted-by":"crossref","first-page":"14366","DOI":"10.1016\/S0021-9258(18)47947-1","article-title":"The L- and R-type isozymes of rat pyruvate kinase are produced from a single gene by use of different promoters.","volume":"262","author":"Noguchi","year":"1987","journal-title":"J Biol Chem."},{"key":"2019111822183763800_B9","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/0006-291X(92)91086-6","article-title":"Structural analysis of human pyruvate kinase L-gene and identification of the promoter activity in erythroid cells.","volume":"188","author":"Kanno","year":"1992","journal-title":"Biochem Biophys Res Commun."},{"key":"2019111822183763800_B10","doi-asserted-by":"crossref","first-page":"5431","DOI":"10.1016\/S0021-9258(18)53339-1","article-title":"Transcriptional regulation of the pyruvate kinase erythroid-specific promoter.","volume":"268","author":"Max-Audit","year":"1993","journal-title":"J Biol Chem."},{"key":"2019111822183763800_B11","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1046\/j.1365-2141.2000.02283.x","article-title":"A new PKLR gene mutation in the R-type promoter region affects the gene transcription causing pyruvate kinase deficiency.","volume":"110","author":"Manco","year":"2000","journal-title":"Br J Haematol."},{"key":"2019111822183763800_B12","first-page":"272a","article-title":"Novel mutations in the human red cell type pyruvate kinase gene: two promoter mutations in cis, a splice site mutation, a nonsense- and three missense mutations [abstract].","volume":"90(suppl 1)","author":"van Solinge","year":"1997","journal-title":"Blood."},{"key":"2019111822183763800_B13","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/ajh.2830350309","article-title":"Diagnosis of pyruvate kinase deficiency in a transfusion-dependent patient with severe hemolytic anemia.","volume":"35","author":"Rijksen","year":"1990","journal-title":"Am J Hematol."},{"key":"2019111822183763800_B14","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1365-2141.1979.tb03751.x","article-title":"Recommended methods for the characterization of red cell pyruvate kinase variants. International Committee for Standardization in Haematology.","volume":"43","year":"1979","journal-title":"Br J Haematol."},{"key":"2019111822183763800_B15","doi-asserted-by":"crossref","first-page":"4987","DOI":"10.1182\/blood.V90.12.4987","article-title":"Molecular modelling of human red blood cell pyruvate kinase: structural implications of a novel G1091 to a mutation causing severe nonspherocytic hemolytic anemia.","volume":"90","author":"van Solinge","year":"1997","journal-title":"Blood."},{"key":"2019111822183763800_B16","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0378-1119(89)90358-2","article-title":"Site-directed mutagenesis by overlap extension using the polymerase chain reaction.","volume":"77","author":"Ho","year":"1989","journal-title":"Gene."},{"key":"2019111822183763800_B17","first-page":"1583","article-title":"Essential AP-1 and PEA3 binding elements in the human urokinase enhancer display cell type-specific activity.","volume":"6","author":"Nerlov","year":"1991","journal-title":"Oncogene."},{"key":"2019111822183763800_B18","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1093\/nar\/11.5.1475","article-title":"Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.","volume":"11","author":"Dignam","year":"1983","journal-title":"Nucleic Acids Res."},{"key":"2019111822183763800_B19","doi-asserted-by":"crossref","first-page":"5787","DOI":"10.1016\/S0021-9258(18)89090-1","article-title":"The mutational specificity of DNA polymerase-beta during in vitro DNA synthesis: production of frameshift, base substitution, and deletion mutations.","volume":"260","author":"Kunkel","year":"1985","journal-title":"J Biol Chem."},{"key":"2019111822183763800_B20","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/339446a0","article-title":"Cloning of cDNA for the major DNA-binding protein of the erythroid lineage through expression in mammalian cells.","volume":"339","author":"Tsai","year":"1989","journal-title":"Nature."},{"key":"2019111822183763800_B21","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.1182\/blood.V95.11.3585","article-title":"Estimating the prevalence of pyruvate kinase deficiency from the gene frequency in the general white population.","volume":"95","author":"Beutler","year":"2000","journal-title":"Blood."},{"key":"2019111822183763800_B22","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1182\/blood.V98.10.3113","article-title":"Human erythrocyte pyruvate kinase: characterization of the recombinant enzyme and a mutant form (R510Q) causing nonspherocytic hemolytic anemia.","volume":"98","author":"Wang","year":"2001","journal-title":"Blood."},{"key":"2019111822183763800_B23","doi-asserted-by":"crossref","first-page":"8170","DOI":"10.1073\/pnas.95.14.8170","article-title":"Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism?","volume":"95","author":"Beutler","year":"1998","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2019111822183763800_B24","doi-asserted-by":"crossref","first-page":"12128","DOI":"10.1073\/pnas.94.22.12128","article-title":"Gilbert syndrome and glucose-6-phosphate dehydrogenase deficiency: a dose-dependent genetic interaction crucial to neonatal hyperbilirubinemia.","volume":"94","author":"Kaplan","year":"1997","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2019111822183763800_B25","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1182\/blood.V80.3.575.575","article-title":"GATA-binding transcription factors in hematopoietic cells.","volume":"80","author":"Orkin","year":"1992","journal-title":"Blood."},{"key":"2019111822183763800_B26","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/ng0995-9","article-title":"Gotta have GATA.","volume":"11","author":"Simon","year":"1995","journal-title":"Nat Genet."},{"key":"2019111822183763800_B27","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1046\/j.1365-2141.1999.01386.x","article-title":"Identification of a novel promoter mutation in the human pyruvate kinase (PK) LR gene of a patient with severe haemolytic anaemia [erratum appears in Br J Haematol. 2002;119:289].","volume":"105","author":"Kugler","year":"1999","journal-title":"Br J Haematol."},{"key":"2019111822183763800_B28","doi-asserted-by":"crossref","first-page":"5669","DOI":"10.1093\/nar\/20.21.5669","article-title":"In vitro and in vivo protein-DNA interactions on the rat erythroid-specific L' pyruvate kinase gene promoter.","volume":"20","author":"Lacronique","year":"1992","journal-title":"Nucleic Acids Res."},{"key":"2019111822183763800_B29","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1182\/blood.V87.5.1793.1793","article-title":"Functional interaction of GATA1 with erythroid Kruppel-like factor and Sp1 at defined erythroid promoters.","volume":"87","author":"Gregory","year":"1996","journal-title":"Blood."},{"key":"2019111822183763800_B30","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1128\/MCB.15.5.2437","article-title":"Functional synergy and physical interactions of the erythroid transcription factor GATA-1 with the Kruppel family proteins Sp1 and EKLF.","volume":"15","author":"Merika","year":"1995","journal-title":"Mol Cell Biol."},{"key":"2019111822183763800_B31","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1093\/emboj\/16.11.3145","article-title":"The LIM-only protein Lmo2 is a bridging molecule assembling an erythroid, DNA-binding complex which includes the TAL1, E47, GATA-1 and Ldb1\/NLI proteins.","volume":"16","author":"Wadman","year":"1997","journal-title":"EMBO J."},{"key":"2019111822183763800_B32","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1093\/nar\/28.1.316","article-title":"TRANSFAC: an integrated system for gene expression regulation.","volume":"28","author":"Wingender","year":"2000","journal-title":"Nucleic Acids Res."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/101\/4\/1596\/1261609\/h80403001596.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/101\/4\/1596\/1261609\/h80403001596.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,28]],"date-time":"2021-05-28T06:02:49Z","timestamp":1622181769000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/101\/4\/1596\/105909\/Disruption-of-a-novel-regulatory-element-in-the"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,2,15]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2003,2,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2002-07-2321","relation":{},"ISSN":["1528-0020","0006-4971"],"issn-type":[{"value":"1528-0020","type":"electronic"},{"value":"0006-4971","type":"print"}],"subject":[],"published":{"date-parts":[[2003,2,15]]}}}